Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice
Authors:
- 1 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 68 (4) , 304-312
Abstract
Downregulation of adiponectin (APN) multimerization is significantly correlated with the aggravation of myocardial ischemia/reperfusion (MI/R) injury in type 2 diabetes mellitus (T2DM). Resveratrol (RSV) upregulates APN multimerization in adipocytes, but whether RSV improves endogenous APN multimerization and thus attenuates MI/R injury in T2DM mice has never been investigated. T2DM mice were treated with 10 mg/kg RSV daily for 3 weeks, followed by 30 minutes of myocardial ischemia and 3 hours or 24 hours of reperfusion. RSV administration alleviated MI/R injury in diabetic mice, as evidenced by reduced infarct size, cardiomyocyte apoptosis, and caspase-3 activity, and improved cardiac function. Moreover, RSV reversed the downregulated APN levels and multimerization both in plasma and adipose tissue, accompanied by increased disulfide bond A oxidoreductase-like protein (DsbA-L) expression in T2DM mice. Conversely, serving as a key downstream molecule of APN in ameliorating MI/R injury, inhibition of AMP-activated protein kinase (AMPK) significantly attenuated the cardioprotective effects of RSV. In conclusion, long-term administration of RSV upregulates adiponectin levels and multimerization in T2DM mice, consequently attenuating MI/R injury partially through APN-AMPK signaling.Keywords
This publication has 31 references indexed in Scilit:
- Reduced Cardioprotective Action of Adiponectin in High-Fat Diet–Induced Type II Diabetic Mice and Its Underlying MechanismsAntioxidants & Redox Signaling, 2011
- Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Resveratrol Shows Vasoprotective Effect Reducing Oxidative Stress Without Affecting Metabolic Disturbances in Insulin-dependent Diabetes of RabbitsCardiovascular Drugs and Therapy, 2011
- Post-translational modifications of adiponectin: mechanisms and functional implicationsBiochemical Journal, 2008
- Diabetes and Mortality Following Acute Coronary SyndromesJAMA, 2007
- High Molecular Weight Adiponectin as a Predictor of Long-Term Clinical Outcome in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2007
- Resveratrol: A Therapeutic Promise for Cardiovascular DiseasesRecent Patents on Cardiovascular Drug Discovery, 2007
- Selective purification and characterization of adiponectin multimer species from human plasmaBiochemical and Biophysical Research Communications, 2007
- Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative StressCirculation, 2007
- Alcohol, Type of Alcohol, and All‐Cause and Coronary Heart Disease MortalityAnnals of the New York Academy of Sciences, 2002